LA CIOTAT, France — November 13, 2025 — Leads & Copy — Medical imaging AI company Avicenna.AI has launched AVI, a new platform designed to seamlessly deliver AI results into healthcare ecosystems.
AVI provides healthcare organizations with fast and flexible access to imaging AI solutions, integrating results into existing workflows automatically and invisibly to end users. The platform integrates directly with PACS and RIS, eliminating the need for additional viewers or changes to clinical workflows.
According to Avicenna.AI, clinicians can continue using their existing tools, while IT teams benefit from simplified deployment. Finance leaders can also expect a lower total cost of ownership through reduced maintenance and support needs.
Cyril Di Grandi, co-founder and CEO of Avicenna.AI, said the platform makes AI work the way it should, requiring no extra training, workflow changes, new viewers, or additional clicks.
AVI’s centralized configuration and orchestration are designed to simplify IT operations, with a one-time integration providing access to all applications on the platform. The platform can host any imaging AI application and will initially offer access to Avicenna’s entire CINA portfolio, including solutions for:
- Intracranial hemorrhage (CINA-ICH)
- Large vessel occlusion (CINA-LVO)
- Aortic dissection (CINA-AD)
- Pulmonary embolism (CINA-PE and CINA-iPE)
- Vertical compression fractures (CINA-VCF and CINA-VCF Quantix)
- Cervical spine fractures (CINA-CSpine)
- ASPECT Score for quantification of stroke severity (CINA-ASPECTS)
Avicenna.AI reports that AVI combines speed and scalability with maximum performance and quality and has been developed for hospitals, healthcare networks, and teleradiology groups seeking to benefit from imaging AI applications.
The platform enables plug-and-play AI implementation with a minimal footprint, is cost-effective, scales from single sites to large networks, and integrates into existing healthcare systems via global standards such as DICOM, HL7, and FHIR.
AVI is built with security at its core, supporting GDPR- and HIPAA-compliant workflows. Data is de-identified before processing and re-identified upon return, with encryption, access controls, and auditable operations ensuring patient privacy.
Avicenna.AI specializes in healthcare AI solutions that utilize deep learning to identify, detect, and quantify severe pathologies from CT medical images. The company aims to accelerate therapeutic decision-making processes and enhance patient outcomes through its AI-based radiology solutions.
Cyril Di Grandi, Co-founder and CEO of Avicenna.AI
Source: Avicenna.AI
